Search

Displaying results 5811 - 5820 of 7479 in total
  1. Drug

    Asnuciclib

    go.drugbank.com/drugs/DB21530
    Experimental

    Asnuciclib has a monoisotopic molecular weight of 394.07 Da.

  2. Drug

    Neracorvir

    go.drugbank.com/drugs/DB21630
    Experimental

    Neracorvir has a monoisotopic molecular weight of 419.12 Da.

  3. Drug

    Clofutriben

    go.drugbank.com/drugs/DB21636
    Investigational

    Clofutriben has a monoisotopic molecular weight of 424.09 Da.

  4. Drug

    Tacaciclib

    go.drugbank.com/drugs/DB21644
    Experimental

    Tacaciclib has a monoisotopic molecular weight of 528.28 Da.

  5. Drug

    Fovinaciclib

    go.drugbank.com/drugs/DB21721
    Investigational

    Fovinaciclib has a monoisotopic molecular weight of 548.3 Da.

  6. Drug

    Zeprumetostat

    go.drugbank.com/drugs/DB21740
    Investigational

    Zeprumetostat has a monoisotopic molecular weight of 548.34 Da.

  7. Drug

    Sodium zirconium cyclosilicate

    go.drugbank.com/drugs/DB14048
    ApprovedInvestigational

    Sodium zirconium cyclosilicate is approved as the trade product Lokelma developed by AstraZeneca - an insoluble, non-absorbed sodium zirconium silicate, formulated as a powder for oral suspension that

  8. Drug

    ENTR-601-44

    go.drugbank.com/drugs/DB17836
    Investigational

    ENTR-601-44 is an exon 44 skipping phosphorodiamidate morpholino oligonucleotide (PMO). Developed by Entrada Therapeutics, it was investigated for the treatment of Duchenne muscular dystrophy.[L46641]

  9. Drug

    GB-13

    go.drugbank.com/drugs/DB18387
    Experimental

    GB-13 is a genetically engineered recombinant protein consisting of an IL13Ra2-targeted genetically engineered mutant of IL-13 and PE4E, a derivative of Pseudomonas exotoxin A.

  10. Drug

    PAS-004

    go.drugbank.com/drugs/DB18611
    Investigational

    PAS-004 is an allosteric MEK 1/2 inhibitor being developed by Pasithea Therapeutics. It is being investigated for the treatment of neurofibromatosis 1 and Noonan syndrome.